Category: Neurological

Neurological

Fyzical Announces 2025 Fight the Fall Campaign

Fyzical Therapy and Balance Centers has launched its 2025 "Fight the Fall" campaign in partnership with the Vestibular Disorders Association.

Neurological

NeuroShield Helmet Concept Promotes TBI Prevention

By showcasing the Neuroshield idealized version of head protection, Brooks Rehabilitation aims to educate the public on TBI prevention.

Neurological

Q&A: Promoting Patient Physical Activity and Preventing Falls

Deborah Jehu, PhD, highlights strategies for promoting physical activity while preventing falls in older adults.

Brain Injury

NIH Funding Research to Investigate TBI-Dementia Link

An international team of researchers led by Penn Medicine will investigate the link between TBI and dementias over the next five years.

Functional Electrical Stimulation

Study: Product Improves Gait in Patients with Foot Drop, MS

The real-world study evaluated the impact of this approach to address neuromuscular walking challenges associated with foot drop.

Gait & Balance

OneStep Secures Funding for Gait Analysis Tool

OneStep has secured $36 million to expand its smartphone-based gait analysis technology, aiming to make gait a widely-recognized "sixth vital sign" for health monitoring and disease management.

Multiple Sclerosis

Case Western Reserve Awarded $1M for New MS Treatment Approach Study

A research team at Case Western Reserve University is pioneering a novel approach to multiple sclerosis treatment by targeting toxic astrocytes, with the goal of protecting and regenerating nerve cells.

Strokes

Study: Black Stroke Patients Arrive Later to Hospitals

Black stroke patients arrive later to emergency departments, and EMS is less likely to notify hospitals of their condition ahead of time, a national study shows.

Parkinson’s Disease

Dosing Begins in Solengepras Parkinson’s Therapy Phase 3 Trial

Cerevance has initiated the Phase 3 ARISE trial to evaluate solengepras, a non-dopaminergic therapy targeting specific brain circuits, as a potential adjunctive treatment for Parkinson's disease.